Condition
Recurrent Acute Lymphoblastic Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Recurrent Acute Lymphoblastic Leukemia clinical trials that are recruiting, in United States. By phase: Phase 1 (3), Phase 2 (2), Phase 1/2 (2). The most active sponsors are Fred Hutchinson Cancer Center (3), M.D. Anderson Cancer Center (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest Recurrent Acute Lymphoblastic Leukemia clinical trials
All recruiting trials (7)
-
CAR T cell therapy for children with acute lymphoblastic leukemia
This study is testing a new type of CAR T cell therapy to see if it can safely help children and young adults with hard-to-treat leukemia.
-
Genetically engineered CAR T-cells for treating certain blood cancers
This study is testing a new type of treatment using specially modified immune cells to see if they can help people with certain blood cancers that haven't responded to other treatments.
-
Using a radioactive antibody followed by stem cell transplant to treat high-risk leukemia or myelodysplastic syndrome
This study is testing a new radioactive treatment combined with a stem cell transplant to see if it can help people with high-risk leukemia or myelodysplastic syndrome feel better and improve their chances of recovery.
-
HA-1 TCR T cell therapy for leukemia that returned or didn't respond after a donor stem cell transplant
This Phase 1 study will test whether giving specially engineered donor T cells called HA-1 TCR T cells is safe and what dose works for people whose acute leukemia came back or didn't respond after a donor stem cell transplant.
-
Combining blinatumomab, methotrexate, cytarabine, and ponatinib for treating certain types of leukemia
This study is testing a new combination of four medications to see if it can help people with certain types of leukemia that have come back or didn't respond to previous treatments.
-
Combination chemotherapy for relapsed or refractory acute lymphoblastic leukemia and related conditions
This study is testing a new combination of chemotherapy drugs to see if it can help people with relapsed or hard-to-treat acute lymphoblastic leukemia and related blood cancers feel better and live longer.
-
Using radioactive treatment before stem cell transplant for high-risk leukemia patients
This study is testing a new radioactive treatment given before a stem cell transplant to see if it can help high-risk leukemia patients by targeting cancer cells while protecting healthy ones.
Related topics
Quick answers
How many Recurrent Acute Lymphoblastic Leukemia clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.